HEART FAILURE
09.00 - 10.30
Chairmen: S. VARNOUS, G. LEBRETON, R. ISNARD
-
Mitral regurgitation in poor LVEF patients: mitraclip controversy
J.-F. OBADIA
-
Refractory heart failure: treatment update
L. SEBBAG
-
National cardiac transplant waiting list: new data?
R. DORENT
-
Preserved EF heart failure: recent data
R. ISNARD
-
Cardiomem device in heart failure patients follow-up
F. ROUBILLE
-
Place of Levosimendan in heart failure therapeutic options
A. HERPAIN
TRANSPLANTATION
11.00 - 12.45
Chairmen: S. VARNOUS, A. BOUGLE, P. LEPRINCE
-
Thoracic organ transplantation: 2018 report
O. BASTIEN
-
Heart allocation score at 2 years
R. DORENT
-
-
Heart allocation score and its limitations
-
Machine learning to predict primary graft dysfunction
B. FINE
-
Interest of vasoactive-inotropic score in early hemodynamic evaluation after cardiac transplantation
M. KINDO
HEART TRANSPLANTATION
14.00 - 15.30
Chairmen: G. COUTANCE, E. EPAILLY, G. LEBRETON
-
The role of molecular microscopy in patient with “no rejection” cardiac allograft dysfunction
J. PATEL
-
Does the sun make us happier? Role of photophoresis in humoral cardiac graft rejection treatment
E. EPAILLY, C. GOÉMINNE
-
US Guidelines for immunized patients in cardiac transplantation
J. PATEL
-
-
Complex clinical case on CMV infection
P. BATTISTELLA
HEART TRANSPLANTATION
16.00 - 18.00
Chairmen: S. VARNOUS, L. NGUYEN, P. BATTISTELLA
-
Bronchial suture related complications in lung transplantation
P. LACOSTE
-
A cohort of heart transplanted patients with antibody mediated rejection
E. VERMES
-
Anti HLA antibodies screening: toward more details and precision
J.-L. TAUPIN
-
Impact of the waiting list registration number on graft acceptance
J. COPELAND
-
Heart transplantation in patients treated with direct oral anticoagulant: Leuven experience
J. VAN KEER
-
Heart transplantation in patients treated with direct oral anticoagulant: Montpellier experience
P. BATTISTELLA
-
Quadritherapy immunosuppressive treatment: Result at 5 years
L. NGUYEN
-
Proposal for a national multicenter trial
L. NGUYEN
-
-
Rhinosinusal murcomycosis in a heart transplant patient
A. BOIGNARD
ECMO
08.30 - 10.30
Chairmen: G. LEBRETON, A. COMBES, A. LANCELOT
-
Cardiogenic shock epidemiology in France
C. DELMAS
-
ECMO, ECLS, ECOS… new nomenclature
A. COMBES
-
Pediatric ECMO mobile unit
V. FOUILLOUX
-
-
French randomized trial in the pipe
A. COMBES
-
Ecpella concept
M. SCANDROGLIO
-
Percutaneous Ecmo canula ablation: Manta device
G. LEBRETON
-
ECMO canula colonisation and infection
F. STEPHAN
-
ECMO and Levosimendan: Myocardial oxygen consumption spearing?
A. HERPAIN
ASSISTANCE CIRCULATOIRE I
11.00 - 13.00
Chairmen: P. LEPRINCE, S. VARNOUS, L. BARANDON
-
-
A patient on ECMO should be considered as
-
-
-
LATERAL trial
J.-C. ROUSSEL
-
The electrophysiologist and LVAD
X. WAINTRAUB
-
Home discharge of Jarvik 2000 patients
G. LEBRETON
-
-
ASSISTANCE CIRCULATOIRE II
14.00 - 16.10
Chairmen: P. LEPRINCE, G. LEBRETON, E. FLÉCHER
-
HVAD vs HM3 – is there a difference or is it just artful statistics and pixie dust?
D. ZIMPFER
-
Pulsatility: myth or reality?
J. COPELAND
-
National trial on therapeutic training of LVAD patients
C. GOÉMINNE
-
Technology and data development updates on SynCardia TAH D
D.- J. WEBBER
-
-
-
Telemedicine to follow LVAD outpatients
C. DELMAS
-
-
PROFESSIONAL DEVELOPMENT FOR NURSES
09.00 - 10.30
Chairmen: S. BOVAGNET, J. GEROL, G. LEBRETON
-
Thoracic organ transplantation: 2018 report
O. BASTIEN
-
Heart allocation score: update
R. DORENT
-
Maastricht 3: who, when, what, how?
V. JUSTICE, A. DUFOUR, G. LEBRETON
-
Transplant coordinator: organization and aim. Example in liver transplantation
L. GOMPLEWICZ
11.00 - 12.30
Chairmen: L. HEMANI, L. GUIDEZ, P. LEPRINCE
-
ICU nurse training for Ecmo survey based on high fi delity simulation
B. GUINARD
-
Two randomized trial in nurse care
C. MOSSADEGH
-
Evaluation of chlorhexidine based dressing
-
Role of family members’ participation in ICU patient care
-
Salpêtrière transplanted patients association
J. CAMUS
-
-
13.30 - 15.00
Chairmen: C. JOUYS, S. VARNOUS, C. LE CORRE
-
-
Evolution of nursing care organization: advanced cooperation and practical deployment
S. ALLEAUME
-
From coordination to advanced practice nurse: which evolution?
L. VIDELOUP
-
Advanced practices in nursing care in Toulouse nephrology and organ transplantation department
C. COUAT
-
Perfusionist, VAD coordinator….: a new Master formation
G. LEBRETON
15.30 - 17.00
Chairmen: P. LEPRINCE, S. BOVAGNET, S. RUGARD
-
Therapeutic training game: experience report
C. BLONDEAU
-
Prospective comparison of QOL in patient LVAD and heart transplanted patients
P. ROUAULT
-
Jarvik 2000: surgical implantation specifi cities
L. HERMANN, M. MORAND
-
Proposal for a national trial on therapeutic education of LVAD patients
C. GOÉMINNE
-
-
Francemacs registry update
P. LEPRINCE
18.30 - 20.45
SYMPOSIUM Therakos sur ECP
18.30 - 18.35
Moderator: Dr Shaida Varnous Pitié Salpêtrière Hospital, Paris, France
Introduction
18.35 - 19.00
Prof. Richard Dorent Bichat Hospital, Paris, France
Current unmet needs in the management of heart transplant patients
19.00 - 19.30
Dr. Eric Epailly Cardiology Strasbourg University Hospital, France
ECP use after heart transplantation: mechanism of action, and the French experience
19.30 - 20.00
Prof. Balazs Sax, Semmelweis University, Budapest, Hungary
ECP use after heart transplantation: the Hungarian experience
20.00 - 20.30
Dr. Massimo Maccherini Hospital SM Le Scotte, Siena, Italy
ECP use after heart transplantation: the Italian experience
20.30 - 20.45
Moderator: Dr Shaida Varnous Pitié Salpêtrière Hospital, Paris, France
Discussion and Conclusions
To see the replay of this day, click here